Reuters: Regulatory News: AstraZeneca gets U.S. subpoena over UK drug factory

Reuters: Regulatory News Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals. // via fulltextrssfeed.com

AstraZeneca gets U.S. subpoena over UK drug factory Apr 25th 2013, 09:22 LONDON, April 25 | Thu Apr 25, 2013 5:22am EDT LONDON, April 25 (Reuters) - AstraZeneca said on Thursday it had received a subpoena from the U.S. Attorney's Office in Boston, Massachusetts, related to manufacturing standards at its Macclesfield facility in the north of England. Britain's second biggest drugmaker said the approach was made on March 28 and the company was coordinating its response and intended to cooperate with the inquiry. Chief Financial Officer Simon Lowth declined to go into further details about the case during a conference call with reporters following first-quarter results. "It's a very early approach," he said. The Macclesfield facility is AstraZeneca's second largest manufacturing site and its European centre for packing medicines. More than 800 people work at the site on the manufacturing, packing and distribution of drugs for 130 global markets. The facility includes a unique production line for making Zoladex, used to treat hormone-sensitive cancers of the prostate and breast, according to AstraZeneca's website.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions